FI971831A0 - Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina - Google Patents

Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina

Info

Publication number
FI971831A0
FI971831A0 FI971831A FI971831A FI971831A0 FI 971831 A0 FI971831 A0 FI 971831A0 FI 971831 A FI971831 A FI 971831A FI 971831 A FI971831 A FI 971831A FI 971831 A0 FI971831 A0 FI 971831A0
Authority
FI
Finland
Prior art keywords
acid derivatives
propenoic acid
heterocycle
nmda antagonists
substituted propenoic
Prior art date
Application number
FI971831A
Other languages
English (en)
Swedish (sv)
Other versions
FI971831A (fi
Inventor
Boyd Lynn Harrison
Philip Lee Nyce
Robert Allan Farr
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of FI971831A publication Critical patent/FI971831A/fi
Publication of FI971831A0 publication Critical patent/FI971831A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI971831A 1994-10-31 1997-04-29 Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina FI971831A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08332016 US5563157B1 (en) 1994-10-31 1994-10-31 Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
PCT/US1995/012085 WO1996013501A1 (en) 1994-10-31 1995-09-21 Heterocycle substituted propenoic acid derivatives as nmda antagonists

Publications (2)

Publication Number Publication Date
FI971831A FI971831A (fi) 1997-04-29
FI971831A0 true FI971831A0 (fi) 1997-04-29

Family

ID=23296353

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971831A FI971831A0 (fi) 1994-10-31 1997-04-29 Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina

Country Status (21)

Country Link
US (3) US5563157B1 (fi)
EP (1) EP0790994B1 (fi)
JP (1) JP3934678B2 (fi)
KR (1) KR100401138B1 (fi)
CN (1) CN1068001C (fi)
AT (1) ATE217307T1 (fi)
AU (1) AU696423B2 (fi)
CA (1) CA2202992C (fi)
DE (1) DE69526668T2 (fi)
DK (1) DK0790994T3 (fi)
ES (1) ES2173198T3 (fi)
FI (1) FI971831A0 (fi)
HU (1) HU222372B1 (fi)
IL (1) IL115791A (fi)
MX (1) MX9703146A (fi)
NO (1) NO313197B1 (fi)
NZ (1) NZ293842A (fi)
PT (1) PT790994E (fi)
TW (1) TW336232B (fi)
WO (1) WO1996013501A1 (fi)
ZA (1) ZA959046B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
EP1341761A1 (en) 2000-10-10 2003-09-10 Smithkline Beecham Corporation SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
AU2002250256B2 (en) * 2001-03-08 2008-04-03 Emory University pH-dependent NMDA receptor antagonists
MX2009014216A (es) * 2007-06-29 2010-07-05 Univ Emory Antagonistas del receptor nmda para neuroproteccion.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0178469B1 (ko) * 1990-07-16 1999-03-20 메이나드 알. 존슨 흥분성 아미노산 길항제
EP0553278B1 (en) * 1990-10-15 1997-06-04 Astra Aktiebolag 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
CN1051302C (zh) * 1993-05-27 2000-04-12 默里尔药物公司 3-(吲哚-3-基)丙烯酸衍生物及其用作nmda拮抗剂

Also Published As

Publication number Publication date
EP0790994A1 (en) 1997-08-27
JPH10508019A (ja) 1998-08-04
ES2173198T3 (es) 2002-10-16
TW336232B (en) 1998-07-11
HUT77174A (hu) 1998-03-02
CA2202992A1 (en) 1996-05-09
HU222372B1 (hu) 2003-06-28
ZA959046B (en) 1996-05-17
IL115791A0 (en) 1996-01-19
US5981553A (en) 1999-11-09
FI971831A (fi) 1997-04-29
AU696423B2 (en) 1998-09-10
DE69526668D1 (de) 2002-06-13
CN1161696A (zh) 1997-10-08
US5563157B1 (en) 1999-02-02
AU3638795A (en) 1996-05-23
DK0790994T3 (da) 2002-08-26
EP0790994B1 (en) 2002-05-08
NO971991L (no) 1997-04-29
IL115791A (en) 2000-09-28
DE69526668T2 (de) 2003-01-02
NO971991D0 (no) 1997-04-29
MX9703146A (es) 1997-06-28
NZ293842A (en) 1998-09-24
US5563157A (en) 1996-10-08
PT790994E (pt) 2002-08-30
KR100401138B1 (ko) 2003-12-24
CN1068001C (zh) 2001-07-04
CA2202992C (en) 2003-05-13
WO1996013501A1 (en) 1996-05-09
NO313197B1 (no) 2002-08-26
US6180786B1 (en) 2001-01-30
ATE217307T1 (de) 2002-05-15
JP3934678B2 (ja) 2007-06-20

Similar Documents

Publication Publication Date Title
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
YU104690A (sh) Supstituisani imidazo-kondenzovani 6-člani heterocikli kao antagonisti angiotenzina 2
SE9504661D0 (sv) New compounds
PT1109812E (pt) Pirrolobenzodiazepinas
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
ES2162676T3 (es) Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3.
EE03869B1 (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
SE8406585D0 (sv) Benzoic acid derivatives
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
ES2180573T3 (es) Uso de derivados de indol como antagonistas de 5ht1.
DE60131001D1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
ATE259813T1 (de) Triazolopyrimidinderivate
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
FI971831A (fi) Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina
SE9504662D0 (sv) New compounds
BG103502A (en) Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
RS49904B (sr) Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida
DE69526738T2 (de) Endothelin-rezeptor-antagonisten
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao

Legal Events

Date Code Title Description
MA Patent expired